CoChat

The brain on time: links between development and neurodegeneration

Shabani, Khadijeh, Hassan, Bassem A. · 2023 · Development
Cited by 41

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Neurodegenerative diseases are characterized by the progressive loss of structure or function of neurons. In this Spotlight, we explore the idea that genetic forms of neurodegenerative disorders might be rooted in neural development. Focusing on Alzheimer's, Parkinson's and Huntington's disease, we first provide a brief overview of the pathology for these diseases. Although neurodegenerative diseases are generally thought of as late-onset diseases, we discuss recent evidence promoting the notion that they might be considered neurodevelopmental disorders. With this view in mind, we consider the suitability of animal models for studying these diseases, highlighting human-specific features of human brain development. We conclude by proposing that one such feature, human-specific regulation of neurogenic time, might be key to understanding the etiology and pathophysiology of human neurodegenerative disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/dev.200397

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 75

  1. Anwar, 2019, Juvenile Parkinson disease, Cureus, 11, e5409, 10.7759/cureus.5409 · DOI
  2. Arai, 2011, Neural stem and progenitor cells shorten S-phase on commitment to neuron production, Nat. Commun., 2, 154, 10.1038/ncomms1155 · DOI · Paper page
  3. Arendt, 2001, Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization, Neuroscience, 102, 723, 10.1016/s0306-4522(00)00516-9 · DOI · Paper page
  4. Arendt, 2017, Is sporadic Alzheimer's disease a developmental disorder?, J. Neurochem., 143, 396, 10.1111/jnc.14036 · DOI
  5. Arteaga-Bracho, 2016, Postnatal and adult consequences of loss of huntingtin during development: implications for Huntington's disease, Neurobiol. Dis., 96, 144, 10.1016/j.nbd.2016.09.006 · DOI · Paper page
  6. Beitz, 2014, School of Nursing-Camden, Rutgers University, 311 N. 5, Front. Biosci., 6, 65, 10.2741/S415 · DOI · Paper page
  7. Benito-Kwiecinski, 2021, An early cell shape transition drives evolutionary expansion of the human forebrain, Cell, 184, 2084, 10.1016/j.cell.2021.02.050 · DOI · Paper page
  8. Bergmans, 2010, Neurons generated from APP/APLP1/APLP2 triple knockout embryonic stem cells behave normally in vitro and in vivo: lack of evidence for a cell autonomous role of the amyloid precursor protein in neuronal differentiation, Stem Cells, 28, 399, 10.1002/stem.296 · DOI
  9. Brunkan, 2005, Presenilin function and γ-secretase activity, J. Neurochem., 93, 769, 10.1111/j.1471-4159.2005.03099.x · DOI · Paper page
  10. Cáceres, 2007, Increased cortical expression of two synaptogenic thrombospondins in human brain evolution, Cereb. Cortex, 17, 2312, 10.1093/cercor/bhl140 · DOI · Paper page
  11. Carmona, 2018, The genetic landscape of Alzheimer disease, Handb. Clin. Neurol., 148, 395, 10.1016/B978-0-444-64076-5.00026-0 · DOI
  12. Cherian, 2020, Genetics of Parkinson's disease, Acta Neurol. Belg., 120, 1297, 10.1007/s13760-020-01473-5 · DOI
  13. Choudhary, 2017, A case report of juvenile Huntington disease, J. Pediatr. Neonatal Individ. Med., 6, e060217, 10.7363/060217 · doi:10.7363/060217
  14. Conforti, 2018, Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes, Proc. Natl. Acad. Sci. USA, 115, E762, 10.1073/pnas.1715865115 · DOI · Paper page
  15. Cookson, 2016, Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease, Biochem. Soc. Trans., 44, 1603, 10.1042/BST20160228 · DOI · Paper page
  16. Dady, 2022, Human spinal cord in vitro differentiation pace is initially maintained in heterologous embryonic environments, eLife, 11, e67283, 10.7554/eLife.67283 · DOI
  17. Doan, 2016, Mutations in human accelerated regions disrupt cognition and social behavior, Cell, 167, 341, 10.1016/j.cell.2016.08.071 · DOI · Paper page
  18. Evans, 2013, Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records, J. Neurol. Neurosurg. Psychiatry, 84, 1156, 10.1136/jnnp-2012-304636 · DOI · Paper page
  19. Florio, 2014, Neural progenitors, neurogenesis and the evolution of the neocortex, Develoment, 141, 2182, 10.1242/dev.090571 · DOI · Paper page
  20. Florio, 2017, Human-specific genomic signatures of neocortical expansion, Curr. Opin. Neurobiol., 42, 33, 10.1016/j.conb.2016.11.004 · DOI
  21. Florio, 2018, Evolution and cell-type specificity of human-specific genes preferentially expressed in progenitors of fetal neocortex, eLife, 7, 1, 10.7554/eLife.32332 · DOI · Paper page
  22. Funayama, 2002, A new locus for Parkinson's Disease (PARK8) maps to chromosome 12p11.2-q13.1, Ann. Neurol., 51, 296, 10.1002/ana.10113 · DOI · Paper page
  23. Galgoczi, 2021, Huntingtin CAG expansion impairs germ layer patterning in synthetic human 2D gastruloids through polarity defects, Development, 148, dev199513, 10.1242/dev.199513 · DOI
  24. Godin, 2010, Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis, Neuron, 67, 392, 10.1016/j.neuron.2010.06.027 · DOI · Paper page
  25. Gralle, 2009, Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers, J. Biol. Chem., 284, 15016, 10.1074/jbc.M808755200 · DOI · Paper page
  26. Güner, 2020, The substrate repertoire of γ-secretase/presenilin, Semin. Cell Dev. Biol., 105, 27, 10.1016/j.semcdb.2020.05.019 · DOI · Paper page
  27. Haass, 2000, Presenilin proteins and their function during embryonic development and Alzheimer's disease, Ernst Schering Res. Found. Workshop, 29, 57, 10.1007/978-3-662-04264-9_4 · DOI
  28. Hartmann, 1999, Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly, Curr. Biol., 9, 719, 10.1016/S0960-9822(99)80331-5 · DOI
  29. Heide, 2020, Human-specific ARHGAP11B increases size and folding of primate neocortex in the fetal marmoset, Science, 369, 546, 10.1126/science.abb2401 · DOI · Paper page
  30. Hu, 2013, Role of cystatin C in amyloid precursor protein-induced proliferation of neural stem/progenitor cells, J. Biol. Chem., 288, 18853, 10.1074/jbc.M112.443671 · DOI
  31. Iennaco, 2022, The evolutionary history of the polyQ tract in huntingtin sheds light on its functional pro-neural activities, Cell Death Differ., 29, 293, 10.1038/s41418-021-00914-9 · DOI
  32. Iwata, 2020, Mitochondrial dynamics in postmitotic cells regulate neurogenesis, Science, 369, 858, 10.1126/science.aba9760 · DOI · Paper page
  33. Jongen, 1980, Seven cases of huntington's disease in childhood and levodopa induced improvement in the hypokinetic - Rigid form, Clin. Neurol. Neurosurg., 82, 251, 10.1016/0303-8467(80)90017-7 · DOI
  34. Kalebic, 2019, Neocortical expansion due to increased proliferation of basal progenitors is linked to changes in their morphology, Cell Stem Cell, 24, 535, 10.1016/j.stem.2019.02.017 · DOI · Paper page
  35. Kim, 2014, Alpha-synuclein biology in Lewy body diseases, Alzheimer's Res. Ther., 6, 73, 10.1186/s13195-014-0073-2 · DOI · Paper page
  36. Kim, 2021, New avenues for the treatment of huntington's disease, Int. J. Mol. Sci., 22, 8363, 10.3390/ijms22168363 · DOI · Paper page
  37. Klein, 2012, Genetics of Parkinson's disease, Cold Spring Harb. Perspect. Med., 2, a008888, 10.1101/cshperspect.a008888 · DOI · Paper page
  38. Kornack, 1995, Radial and horizontal deployment of clonally related cells in the primate neocortex: relationship to distinct mitotic lineages, Neuron, 15, 311, 10.1016/0896-6273(95)90036-5 · DOI · Paper page
  39. Krumova, 2015, Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate, FASEB J., 29, 2980, 10.1096/fj.14-262329 · DOI
  40. Lesinskien, 2020, Juvenile Huntington's disease: two case reports and a review of the literature, J. Med. Case Rep., 14, 173, 10.1186/s13256-020-02494-7 · DOI
  41. Lewitus, 2014, An adaptive threshold in mammalian neocortical evolution, PLoS Biol., 12, e1002000, 10.1371/journal.pbio.1002000 · DOI · Paper page
  42. Liu, 2021, The amyloid precursor protein is a conserved Wnt receptor, eLife, 10, e69199, 10.7554/eLife.69199 · DOI
  43. Lizama, 2021, Neuronal autophagy and mitophagy in Parkinson's disease, Mol. Aspects Med., 82, 100972, 10.1016/j.mam.2021.100972 · DOI
  44. Lourenço, 2009, Netrin-1 interacts with amyloid precursor protein and regulates amyloid-β production, Cell Death Differ., 16, 655, 10.1038/cdd.2008.191 · DOI · Paper page
  45. Luciana De Andrade, 2019, Juvenile Huntington’ disease: a case of paternal transmission with an uncommon CAG expansion, Clin. Med. Rev. Case Rep., 6, 253, 10.23937/2378-3656/1410253 · DOI
  46. Ma, 2008, A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis, Nat. Cell Biol., 10, 283, 10.1038/ncb1690 · DOI · Paper page
  47. Magistrelli, 2022, A very early onset of juvenile parkinsonism, J. Neurol., 269, 6661, 10.1007/s00415-022-11278-6 · doi:10.1007/s00415-022-11278-6
  48. Matsuda, 2009, BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue Dementia gene BRI2, J. Biol. Chem., 284, 15815, 10.1074/jbc.M109.006403 · DOI
  49. Mckinstry, 2014, Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits, J. Neurosci., 34, 9455, 10.1523/JNEUROSCI.4699-13.2014 · DOI · Paper page
  50. Mendez, 2017, Early-onset Alzheimer disease, Neurol. Clin., 35, 263, 10.1016/j.ncl.2017.01.005 · DOI · Paper page
  51. Moceri, 2000, early-life risk factors and the development of Alzheimer's disease, Neurology, 54, 415, 10.1212/WNL.54.2.415 · DOI · Paper page
  52. Moehlman, 2020, Mitochondrial quality control and restraining innate immunity, 265, 10.1146/annurev-cellbio-021820-101354 · DOI · Paper page
  53. Molero, 2016, Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease, Proc. Natl. Acad. Sci. USA, 113, 5736, 10.1073/pnas.1603871113 · DOI · Paper page
  54. Molina-Calavita, 2014, Mutant huntingtin affects cortical progenitor cell division and development of the mouse neocortex, J. Neurosci., 34, 10034, 10.1523/JNEUROSCI.0715-14.2014 · DOI · Paper page
  55. Nitsche, 2021, Alzheimer-related genes show accelerated evolution, Mol. Psychiatry, 26, 5790, 10.1038/s41380-020-0680-1 · DOI
  56. Paisán-Ruíz, 2004, Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease, Neuron, 44, 595, 10.1016/j.neuron.2004.10.023 · DOI · Paper page
  57. Polioudakis, 2019, A single-cell transcriptomic atlas of human neocortical development during mid-gestation, Neuron, 103, 785, 10.1016/j.neuron.2019.06.011 · DOI · Paper page
  58. Ribaï, 2007, Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 patients, Arch. Neurol., 64, 813, 10.1001/archneur.64.6.813 · DOI
  59. Roosen, 2016, LRRK2 at the interface of autophagosomes, endosomes and lysosomes, Mol. Neurodegener., 11, 73, 10.1186/s13024-016-0140-1 · DOI · Paper page
  60. Saudou, 2016, The biology of Huntingtin, Neuron, 89, 910, 10.1016/j.neuron.2016.02.003 · DOI · Paper page
  61. Savitt, 2006, Diagnosis and treatment of Parkinson disease: molecules to medicine, J. Clin. Invest., 116, 1744, 10.1172/JCI29178 · DOI · Paper page
  62. Shabani, 2021, The temporal balance between self-renewal and differentiation of human neural stem cells requires the amyloid precursor protein, bioRxiv, 10.1101/2021.02.17.431707 · DOI
  63. Shariati, 2013, APLP2 regulates neuronal stem cell differentiation during cortical development, J. Cell Sci., 126, 1268, 10.1242/jcs.122440 · DOI
  64. Sherwood, 2011, Aging of the cerebral cortex differs between humans and chimpanzees, Proc. Natl. Acad. Sci. USA, 108, 13029, 10.1073/pnas.1016709108 · DOI · Paper page
  65. Somel, 2009, Transcriptional neoteny in the human brain, Proc. Natl. Acad. Sci. USA, 106, 5743, 10.1073/pnas.0900544106 · DOI · Paper page
  66. Stepien, 2020, Lengthening neurogenic period during neocortical development causes a hallmark of Neocortex expansion, Curr. Biol., 30, 4227, 10.1016/j.cub.2020.08.046 · DOI
  67. Stepien, 2021, Length of the neurogenic period—a key determinant for the generation of upper-layer neurons during neocortex development and evolution, Front. Cell Dev. Biol., 9, 1218, 10.3389/fcell.2021.676911 · DOI
  68. Stoker, 2022, Huntington's disease: diagnosis and management, Pract. Neurol., 22, 32, 10.1136/practneurol-2021-003074 · DOI · Paper page
  69. Sulzer, 2019, The physiological role of α-synuclein and its relationship to Parkinson's Disease, J. Neurochem., 150, 475, 10.1111/jnc.14810 · DOI · Paper page
  70. Tamayev, 2010, Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis, J. Neurosci., 30, 14915, 10.1523/JNEUROSCI.3917-10.2010 · DOI · Paper page
  71. Tartari, 2008, Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin, Mol. Biol. Evol., 25, 330, 10.1093/molbev/msm258 · DOI · Paper page
  72. Tysnes, 2017, Epidemiology of Parkinson's disease, J. Neural Transm., 124, 901, 10.1007/s00702-017-1686-y · DOI · Paper page
  73. Villar-Piqué, 2016, Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies, J. Neurochem., 139, 240, 10.1111/jnc.13249 · DOI · Paper page
  74. Walter, 2019, Neural stem cells of Parkinson's disease patients exhibit aberrant mitochondrial morphology and functionality, Stem Cell Rep., 12, 878, 10.1016/j.stemcr.2019.03.004 · DOI · Paper page
  75. Wanker, 2019, The pathobiology of perturbed mutant huntingtin protein–protein interactions in Huntington's disease, J. Neurochem., 151, 507, 10.1111/jnc.14853 · DOI

Cited by

See all 41

Metadata

Authors
Shabani, K., & Hassan, B. A.
Affiliations
Institut du Cerveau – Paris Brain Institute – ICM, Sorbonne Université, Inserm, CNRS, Hôpital Pitié-Salpêtrière , 75013 Paris , France
Venue
Development
Published
2023-05-15
Volume
150
Issue
10
ISSN
  • 0950-1991
  • 1477-9129
Cited by
41
References
27
Language
en
Funders
  • Institut du Cerveau-Paris Brain Institute
  • Agence Nationale de la Recherche (ANR-11-INBS-0011-N, ANR-21-CE13-0041-01)
  • National Institutes of Health
  • Association France Alzheimer (2112002NA)
  • Fondation Roger de Spoelberch
  • Fonds de Dotation Neuroglia (2003009NA)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.